leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 22:03:47 - browse：17961

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Biden targets hefty hospital 'facility fees' that often surprise patients

WSS

Is there really a nursing shortage in the U.S.?

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Summit: The economic case for universal basic health care

Presidential fundraising highlights so far: Trump brings in more than DeSantis

STAT Summit: How researchers deal with rejection

The aspartame in Diet Coke probably isn’t giving you cancer

hotspot

leisure time

focus

After affirmative action ruling, medical educators look to 'holistic review'

Parents surprise family after baby discharged from NICU after 170 days

Dobbs anniversary: the lost opportunity of abortion as health care

Study on Amgen’s bispecific immunotherapy produces positive data

Hepatitis C has a cure — but many Americans still lack access to it

Medicare wants to send $9 billion to 340B hospitals

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth, Optum discontinue NaviHealth name

In Memoriam: Notable people who died in 2023

Judge agrees to delay next hearing in Trump classified documents case

explore

Study on Amgen’s bispecific immunotherapy produces positive data

STAT Summit: Ending the crisis of Black deaths in the U.S.

Readout LOUD podcast: Live from the 2023 STAT Summit

UnitedHealth, Optum discontinue NaviHealth name

How AI can help patients find reliable information about doctors

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

focus

focus

leisure time

hotspot